Improving cell-based therapies for cancer treatment
CORE SUPPORT FOR THE IMMUNE CELL NETWORK
This study is looking at ways to improve immune cell treatments for people with cancer or damage from radiation and chemotherapy, aiming to create personalized therapies that can better fight tumors while protecting healthy tissues.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Leidos Biomedical Research, INC. NIH-funded |
| Lab location | 1 site (Frederick, United States) |
| Project ID | NIH-11193419 on NIH RePORTER |
What this research studies
This research focuses on enhancing the engineering of immune cells for clinical use, particularly in treating cancer and tissue damage caused by radiation and chemotherapy. It explores various cell types, including stem cells and lymphocytes, to develop effective immunotherapies. The project aims to overcome challenges in creating patient-specific therapies that effectively target tumors while minimizing damage to healthy tissues. By standardizing analytical methods and addressing manufacturing complexities, the research seeks to advance the application of these 'living drugs' in clinical settings.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients with specific types of cancers, particularly those who have not responded to conventional therapies.
Not a fit: Patients with common cancers that are already effectively treated with standard therapies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and personalized cancer treatments that improve patient outcomes.
How similar studies have performed: Previous research has shown promising results in the field of cell-based immunotherapies, indicating a strong potential for success in this area.
Where this research is happening
Frederick, United States
- Leidos Biomedical Research, INC. — Frederick, United States (Active)
Researchers
- Principal investigator: Dmitrovsky, Ethan — Leidos Biomedical Research, INC.
- Study coordinator: Dmitrovsky, Ethan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.